RiverPark Advisors LLC Sells 126 Shares of Intuitive Surgical, Inc. $ISRG

RiverPark Advisors LLC lowered its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 3.3% during the 2nd quarter, HoldingsChannel reports. The institutional investor owned 3,705 shares of the medical equipment provider’s stock after selling 126 shares during the quarter. Intuitive Surgical accounts for 1.2% of RiverPark Advisors LLC’s holdings, making the stock its 24th largest position. RiverPark Advisors LLC’s holdings in Intuitive Surgical were worth $2,013,000 as of its most recent SEC filing.

A number of other hedge funds also recently made changes to their positions in ISRG. Tobam raised its holdings in shares of Intuitive Surgical by 666.7% during the 2nd quarter. Tobam now owns 46 shares of the medical equipment provider’s stock worth $25,000 after acquiring an additional 40 shares in the last quarter. TD Capital Management LLC boosted its holdings in shares of Intuitive Surgical by 300.0% in the 1st quarter. TD Capital Management LLC now owns 60 shares of the medical equipment provider’s stock worth $30,000 after purchasing an additional 45 shares during the period. 1248 Management LLC bought a new position in shares of Intuitive Surgical during the 1st quarter valued at approximately $30,000. Princeton Global Asset Management LLC purchased a new stake in Intuitive Surgical during the 2nd quarter valued at $30,000. Finally, Bank of Jackson Hole Trust raised its holdings in Intuitive Surgical by 70.5% during the 1st quarter. Bank of Jackson Hole Trust now owns 75 shares of the medical equipment provider’s stock valued at $37,000 after buying an additional 31 shares during the period. 83.64% of the stock is currently owned by hedge funds and other institutional investors.

Intuitive Surgical Price Performance

Shares of ISRG opened at $578.87 on Wednesday. The firm has a market capitalization of $207.51 billion, a price-to-earnings ratio of 76.57, a PEG ratio of 4.94 and a beta of 1.62. Intuitive Surgical, Inc. has a 1-year low of $425.00 and a 1-year high of $616.00. The company has a 50-day moving average of $497.66 and a 200 day moving average of $504.41.

Intuitive Surgical (NASDAQ:ISRG) last issued its earnings results on Tuesday, October 21st. The medical equipment provider reported $2.40 EPS for the quarter, topping analysts’ consensus estimates of $1.99 by $0.41. Intuitive Surgical had a net margin of 28.58% and a return on equity of 15.08%. The business had revenue of $2.51 billion for the quarter, compared to analyst estimates of $2.41 billion. During the same period last year, the company posted $1.84 earnings per share. The company’s quarterly revenue was up 22.9% compared to the same quarter last year. On average, equities analysts anticipate that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Insider Activity at Intuitive Surgical

In other Intuitive Surgical news, EVP Myriam Curet sold 7,562 shares of Intuitive Surgical stock in a transaction on Tuesday, October 28th. The stock was sold at an average price of $548.43, for a total transaction of $4,147,227.66. Following the completion of the sale, the executive vice president directly owned 353 shares of the company’s stock, valued at $193,595.79. The trade was a 95.54% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, EVP Henry L. Charlton sold 13,731 shares of the company’s stock in a transaction on Wednesday, November 12th. The stock was sold at an average price of $580.00, for a total value of $7,963,980.00. Following the completion of the sale, the executive vice president owned 3,056 shares of the company’s stock, valued at $1,772,480. This represents a 81.80% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders sold a total of 116,164 shares of company stock worth $61,916,172 over the last three months. Corporate insiders own 0.70% of the company’s stock.

Analyst Upgrades and Downgrades

Several research firms have commented on ISRG. Jefferies Financial Group lifted their price objective on shares of Intuitive Surgical from $550.00 to $560.00 and gave the stock a “hold” rating in a research note on Wednesday, October 22nd. Evercore ISI lifted their price target on shares of Intuitive Surgical from $450.00 to $540.00 in a research note on Wednesday, October 22nd. Piper Sandler upped their price target on shares of Intuitive Surgical from $595.00 to $610.00 and gave the company an “overweight” rating in a report on Wednesday, October 22nd. Rothschild & Co Redburn raised their price objective on shares of Intuitive Surgical from $610.00 to $615.00 and gave the stock a “buy” rating in a research note on Thursday, October 23rd. Finally, BTIG Research boosted their target price on Intuitive Surgical from $529.00 to $589.00 and gave the company a “buy” rating in a research report on Wednesday, October 22nd. Two equities research analysts have rated the stock with a Strong Buy rating, nineteen have issued a Buy rating, seven have assigned a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $608.92.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.